ECTRIMS: No Benefit from Adding Statin in Early MS, Copenhagen University Hospital Study

MedPageToday -- GOTHENBURG, Sweden -- Adjunctive simvastatin provided no benefit in multiple sclerosis patients taking intramuscular interferon beta-1a (Avonex), results of a new study showed.

MORE ON THIS TOPIC